Clinical trial for women with bacterial vaginosis

What is Bacterial Vaginosis?

Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge in women of reproductive age, but it can also occur in perimenopausal women. It is not a classic sexually transmitted infection, but rather a disruption of the natural balance of vaginal bacteria. The condition involves a decrease in protective lactobacilli (Lactobacillus) and an overgrowth of other anaerobic bacteria, leading to an increased vaginal pH.

Symptoms

Symptoms of bacterial vaginosis include:

  • an increased amount of homogeneous, grayish vaginal discharge
  • characteristic “fishy” odor
  • vulvar irritation may also be observed, presenting as itching, burning sensations, redness of the skin, hypersensitivity during intercourse, and/or pain during urination.

Why Should It Be Treated?

Bacterial vaginosis should not be ignored. If left untreated, it can increase the risk of other vaginal infections and sexually transmitted infections. In pregnant women, BV is associated with a higher risk of complications such as preterm birth or premature rupture of membranes.

Conditions of participation:

* Study duration: 14–15 weeks
** Treatment duration: 7 days

We provide participants with:

Duration of the study

 14-15 weeks

Form


Principal Investigator

lek. Anna Szwabowicz
Szwabowicz-1